<4179> Ginext 293 +10
Rapid rebound. After the end of trading on the 21st, the financial estimates for the 25th fiscal year that had been undisclosed to date were announced to have revenue of 610 million to 670 million yen (6.1 billion yen in the previous year) and an operating loss of 140 million yen to a loss of 100 million yen (a loss of 148 million yen in the previous year). The possibility of an increase in revenue from the previous year and the prospect of a reduction in operating losses were seen as positive factors.
The weather is good today The weather is good today.
Significant decline. After the end of trading on the 21st, it was sold because RS8001 (pyridoxamine), a phase II physician-led study for premenstrual syndrome (PMS)/premenstrual dysphoric disorder (PMDD) with accompanying mental symptoms, announced that there was no statistically significant difference in the primary endpoint of the placebo-controlled double-blind three-group comparison trial. Although a decreasing trend was observed in the active drug group for secondary endpoints, no significant difference was observed.
Please use your Futubull account to access the feature.
Sharply rebounded. After the end of trading on the 21st, the monthly revenue for May was announced. The handling volume was 2.444 billion yen, an increase of 3.6% compared to the same month last year, and the revenue was 344 million yen, an increase of 33.3% compared to the same month last year, which is regarded as good news. The company operates performance-based advertising services and a used construction machinery marketplace-related business, etc. The number of operators who placed ads registered with "Rent Rakkusu" increased by 1,346 people from the previous month, reaching 57,625 people.
<7084> Kids Smile 883 -31
Sharp decline. After the end of trading on the 21st, the performance outlook that was not disclosed was announced. The performance forecast for the 2025 fiscal year is expected to turn into a recurring loss of 130 million yen (compared to the previous year's profit of 311 million yen). While existing businesses are expected to remain strong, the increase in expenses due to investments in new businesses and the strengthening of headquarters functions is the main factor for this year's forecast. In addition, the company has announced plans to expand its business areas and start a new business called the "Postpartum Care Service Business" in its new medium-term management plan.
<9162> Bleach 310 -5
Continues to decline. It announced a revision of financial estimates on the 21st. The company downwardly revised the operating income for the year ending June 2024 to a deficit of 391 million yen (compared to a profit of 2.173 billion yen in the previous year) and the sales revenue to 13.639 billion yen (compared to 16.377 billion yen in the previous year). The reasons included the elapsed product life cycle and changes in sales strategy by some existing customers, as well as the need for more time than anticipated for new product marketing initiatives to take effect. The company also cited changes in external environments, such as the decline in consumer sentiment towards functional food due to voluntary recalls of products by major pharmaceutical companies.
<3479> TKP 1424 +23
Rebounds. It announced a capital business alliance agreement, which includes the use of the equity method for Nova Ltd. It is expected that the company will hold 8,250,000 common shares (33.0% of the total issued shares) of Nova Ltd. as of the 24th. The company expects to achieve synergy effects such as cooperation in M&A strategies for accelerating store expansion, cooperation in property information sharing, promotion of weekday operation of facilities owned by Nova Ltd. and maximum utilization of kitchen facilities. However, the impact of this capital business alliance on the consolidated performance for the fiscal year ending February 2025 is currently under examination.